Ali HA, Li Y, Bilal AHM, Qin T, Yuan Z, Zhao W. A Comprehensive Review of BET Protein Biochemistry, physiology, and pathological roles. Front Pharmacol. 2022;13:818891.
Article CAS PubMed PubMed Central Google Scholar
Avrahami D, Kaestner KH. The dynamic methylome of islets in health and disease. Mol Metab. 2019;27S(Suppl):S25–32.
Bailey D, Jahagirdar R, Gordon A, Hafiane A, Campbell S, Chatur S, Wagner GS, Hansen HC, Chiacchia FS, Johansson J, et al. RVX-208: a small molecule that increases apolipoprotein A-I and high-density lipoprotein cholesterol in vitro and in vivo. J Am Coll Cardiol. 2010;55(23):2580–9.
Article CAS PubMed Google Scholar
Bajbouj K, Al-Ali A, Ramakrishnan RK, Saber-Ayad M, Hamid Q. Histone modification in NSCLC: Molecular mechanisms and therapeutic targets. Int J Mol Sci 2021, 22(21).
Bhat A, Ghatage T, Bhan S, Lahane GP, Dhar A, Kumar R, Pandita RK, Bhat KM, Ramos KS, Pandita TK. Role of transposable elements in Genome Stability: implications for Health and Disease. Int J Mol Sci 2022, 23(14).
Biondi G, Marrano N, Borrelli A, Rella M, D’Oria R, Genchi VA, Caccioppoli C, Cignarelli A, Perrini S, Laviola L et al. The p66(shc) Redox Protein and the emerging complications of diabetes. Int J Mol Sci 2023, 25(1).
Borck PC, Guo LW, Plutzky J. BET Epigenetic Reader Proteins in Cardiovascular Transcriptional Programs. Circ Res. 2020;126(9):1190–208.
Article CAS PubMed PubMed Central Google Scholar
Breschi A, Gingeras TR, Guigo R. Comparative transcriptomics in human and mouse. Nat Rev Genet. 2017;18(7):425–40.
Article CAS PubMed PubMed Central Google Scholar
Bridgeman SC, Ellison GC, Melton PE, Newsholme P, Mamotte CDS. Epigenetic effects of metformin: from molecular mechanisms to clinical implications. Diabetes Obes Metab. 2018;20(7):1553–62.
Brown JD, Lin CY, Duan Q, Griffin G, Federation A, Paranal RM, Bair S, Newton G, Lichtman A, Kung A, et al. NF-kappaB directs dynamic super enhancer formation in inflammation and atherogenesis. Mol Cell. 2014;56(2):219–31.
Article CAS PubMed PubMed Central Google Scholar
Camara AS, Mascher M. Consistencies and contradictions in different polymer models of chromatin architecture. Comput Struct Biotechnol J. 2023;21:1084–91.
Article CAS PubMed PubMed Central Google Scholar
Cavalieri V. The Expanding Constellation of histone post-translational modifications in the Epigenetic Landscape. Genes (Basel) 2021, 12(10).
Cencioni C, Spallotta F, Greco S, Martelli F, Zeiher AM, Gaetano C. Epigenetic mechanisms of hyperglycemic memory. Int J Biochem Cell Biol. 2014;51:155–8.
Article CAS PubMed Google Scholar
Chang HY, Qi LS. Reversing the Central Dogma: RNA-guided control of DNA in epigenetics and genome editing. Mol Cell. 2023;83(3):442–51.
Article CAS PubMed PubMed Central Google Scholar
Chen S, Zou Y, Song C, Cao K, Cai K, Wu Y, Zhang Z, Geng D, Sun W, Ouyang N, et al. The role of glycolytic metabolic pathways in cardiovascular disease and potential therapeutic approaches. Basic Res Cardiol. 2023;118(1):48.
Article CAS PubMed PubMed Central Google Scholar
Cooper ME, El-Osta A. Epigenetics: mechanisms and implications for diabetic complications. Circ Res. 2010;107(12):1403–13.
Article CAS PubMed Google Scholar
Costantino S, Libby P, Kishore R, Tardif JC, El-Osta A, Paneni F. Epigenetics and precision medicine in cardiovascular patients: from basic concepts to the clinical arena. Eur Heart J. 2018;39(47):4150–8.
Article CAS PubMed Google Scholar
Dupont C, Armant DR, Brenner CA. Epigenetics: definition, mechanisms and clinical perspective. Semin Reprod Med. 2009;27(5):351–7.
Article CAS PubMed PubMed Central Google Scholar
Eberharter A, Becker PB. Histone acetylation: a switch between repressive and permissive chromatin. Second in review series on chromatin dynamics. EMBO Rep. 2002;3(3):224–9.
Article CAS PubMed PubMed Central Google Scholar
Ecker S, Pancaldi V, Valencia A, Beck S, Paul DS. Epigenetic and transcriptional variability shape phenotypic plasticity. BioEssays 2018, 40(2).
Eelen G, de Zeeuw P, Simons M, Carmeliet P. Endothelial cell metabolism in normal and diseased vasculature. Circ Res. 2015;116(7):1231–44.
Article CAS PubMed PubMed Central Google Scholar
El-Osta A, Wolffe AP. DNA methylation and histone deacetylation in the control of gene expression: basic biochemistry to human development and disease. Gene Expr. 2000;9(1–2):63–75.
El-Osta A, Brasacchio D, Yao D, Pocai A, Jones PL, Roeder RG, Cooper ME, Brownlee M. Transient high glucose causes persistent epigenetic changes and altered gene expression during subsequent normoglycemia. J Exp Med. 2008;205(10):2409–17.
Article CAS PubMed PubMed Central Google Scholar
Elbere I, Silamikelis I, Ustinova M, Kalnina I, Zaharenko L, Peculis R, Konrade I, Ciuculete DM, Zhukovsky C, Gudra D, et al. Significantly altered peripheral blood cell DNA methylation profile as a result of immediate effect of metformin use in healthy individuals. Clin Epigenetics. 2018;10(1):156.
Article CAS PubMed PubMed Central Google Scholar
Epidemiology of Diabetes I, Complications Research G. Epidemiology of diabetes interventions and complications (EDIC). Design, implementation, and preliminary results of a long-term follow-up of the Diabetes Control and complications Trial cohort. Diabetes Care. 1999;22(1):99–111.
Feng B, Ruiz MA, Chakrabarti S. Oxidative-stress-induced epigenetic changes in chronic diabetic complications. Can J Physiol Pharmacol. 2013;91(3):213–20.
Article CAS PubMed Google Scholar
Galimov ER. The role of p66shc in oxidative stress and apoptosis. Acta Naturae. 2010;2(4):44–51.
Article CAS PubMed PubMed Central Google Scholar
Garmpi A, Damaskos C, Garmpis N, Kaminiotis VV, Georgakopoulou VE, Spandidos DA, Papalexis P, Diamantis E, Patsouras A, Kyriakos G, et al. Role of histone deacetylase inhibitors in diabetic cardiomyopathy in experimental models (review). Med Int (Lond). 2022;2(4):26.
Geraldes P, King GL. Activation of protein kinase C isoforms and its impact on diabetic complications. Circ Res. 2010;106(8):1319–31.
Article CAS PubMed PubMed Central Google Scholar
Giacco F, Brownlee M. Oxidative stress and diabetic complications. Circ Res. 2010;107(9):1058–70.
Article CAS PubMed PubMed Central Google Scholar
Gilham D, Wasiak S, Tsujikawa LM, Halliday C, Norek K, Patel RG, Kulikowski E, Johansson J, Sweeney M, Wong NC, et al. RVX-208, a BET-inhibitor for treating atherosclerotic cardiovascular disease, raises ApoA-I/HDL and represses pathways that contribute to cardiovascular disease. Atherosclerosis. 2016;247:48–57.
Article CAS PubMed Google Scholar
Ginno PA, Lott PL, Christensen HC, Korf I, Chedin F. R-loop formation is a distinctive characteristic of unmethylated human CpG island promoters. Mol Cell. 2012;45(6):814–25.
Article CAS PubMed PubMed Central Google Scholar
Giordo R, Posadino AM, Mangoni AA, Pintus G. Metformin-mediated epigenetic modifications in diabetes and associated conditions: Biological and clinical relevance. Biochem Pharmacol. 2023;215:115732.
留言 (0)